![](/img/cover-not-exists.png)
Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Advanced Hematologic Malignancies: Unexpected Renal Toxicity
K. van Besien, J. Kline, L. Godley, R.A. Larson, O. Odenike, E.S. Rich, W. Stock, A. Wickrema, K. Swanson, S. Horowitz, P. Del Cerro, L. Schroeder, L. Pape, S. Allen, A.S. ArtzVolume:
15
Year:
2009
Language:
english
DOI:
10.1016/j.bbmt.2008.12.324
File:
PDF, 46 KB
english, 2009